Powered by

Powered by Portfolio Grader

Biogen, Inc. (BIIB)

216.71 10.17 (4.48%) 19:59 EDT
BIIB Stock Quote Delayed 15 Minutes
  • BIIB Stock Chart

  • Historical BIIB Prices

 
Dividend & Yield:       N/A (N/A)
P/E:       15.48
Market Cap:       45.73B
EPS:       14
Volume:       8.49M
Day's Range:       216.49 - 226.80
52wk Range:       224.60 - 388.67
Quotes delayed at least 20 mins.
Historical Data for BIIB
Date Open High Low Volume Close Change %
03/22/19 225.10 226.80 216.49 8,490,800 216.71 -10.17   -4.48%
03/21/19 230.07 235.77 224.60 21,612,645 226.88 -93.71   -29.23%
03/20/19 323.67 325.00 320.14 993,440 320.59 -3.17   -0.98%
03/19/19 326.26 327.75 322.40 1,081,877 323.76 -1.88   -0.58%
03/18/19 328.55 330.00 324.28 1,036,164 325.64 -4.23   -1.28%
03/15/19 321.96 330.10 321.96 2,368,000 329.87 8.35   2.60%
03/14/19 321.53 323.55 318.70 1,157,518 321.52 0.96   0.30%
03/13/19 313.12 321.22 312.11 1,107,371 320.56 7.84   2.51%
03/12/19 313.08 315.28 311.26 1,332,443 312.72 1.26   0.40%
03/11/19 308.28 312.15 307.28 1,491,671 311.46 3.53   1.15%
03/08/19 312.29 313.33 305.90 1,602,100 307.93 -7.36   -2.33%
03/07/19 317.11 317.99 314.18 1,078,568 315.29 -2.68   -0.84%
03/06/19 327.49 328.41 317.84 1,007,815 317.97 -8.90   -2.72%
03/05/19 327.75 330.12 325.04 1,000,930 326.87 -0.39   -0.12%
03/04/19 335.60 336.57 324.44 1,046,896 327.26 -6.84   -2.05%
03/01/19 331.29 335.17 330.15 906,300 334.10 6.09   1.86%
02/28/19 327.64 329.78 326.51 752,918 328.01 -0.88   -0.27%
02/27/19 326.53 330.03 325.51 598,458 328.89 1.27   0.39%
02/26/19 327.23 329.15 325.13 742,936 327.62 0.14   0.04%
02/25/19 327.95 331.99 326.25 802,267 327.48 2.15   0.66%
02/22/19 321.19 325.39 320.42 1,029,900 325.33 4.16   1.30%
02/21/19 329.97 331.49 320.39 1,441,237 321.17 -13.99   -4.17%
02/20/19 332.37 335.30 331.57 859,919 335.16 2.16   0.65%
02/19/19 330.83 335.93 330.83 946,754 333.00 0.13   0.04%
02/15/19 328.09 333.28 324.71 1,435,700 332.87 8.16   2.51%
02/14/19 321.00 325.78 318.57 1,245,889 324.71 3.17   0.99%
02/13/19 321.00 323.66 319.23 1,136,776 321.54 2.11   0.66%
02/12/19 319.10 320.31 316.95 1,082,722 319.43 2.56   0.81%
02/11/19 316.12 317.90 314.54 1,360,874 316.87 1.75   0.56%
02/08/19 307.11 316.71 305.45 1,633,700 315.12 6.39   2.07%
02/07/19 323.90 325.20 307.00 2,786,635 308.73 -24.51   -7.36%
02/06/19 337.47 338.41 331.63 933,446 333.24 -3.75   -1.11%
02/05/19 334.33 338.87 333.30 1,246,617 336.99 2.92   0.87%
02/04/19 331.37 334.11 326.61 988,527 334.07 3.16   0.95%
02/01/19 333.75 333.75 326.07 1,180,800 330.91 -2.87   -0.86%
01/31/19 328.24 334.30 325.06 1,417,069 333.78 5.92   1.81%
01/30/19 326.20 330.99 321.42 2,387,943 327.86 -6.62   -1.98%
01/29/19 327.14 335.08 326.01 1,588,910 334.48 4.47   1.35%
01/28/19 335.19 335.88 326.84 1,229,596 330.01 -6.76   -2.01%
01/25/19 334.88 337.36 333.51 999,700 336.77 3.90   1.17%
01/24/19 336.91 337.21 331.97 1,090,897 332.87 -4.35   -1.29%
01/23/19 340.46 344.00 333.29 1,046,759 337.22 -1.74   -0.51%
01/22/19 335.05 340.70 333.66 1,448,413 338.96 1.54   0.46%
01/18/19 340.33 340.55 334.71 1,270,700 337.42 -0.92   -0.27%
01/17/19 331.24 339.96 330.32 982,900 338.34 6.31   1.90%
01/16/19 337.43 339.97 330.06 1,234,654 332.03 -5.51   -1.63%
01/15/19 330.67 337.97 328.93 982,237 337.54 7.12   2.15%
01/14/19 331.28 331.52 327.72 950,075 330.42 -2.79   -0.84%
01/11/19 329.40 333.57 327.83 1,317,800 333.21 2.02   0.61%
01/10/19 325.62 331.37 324.20 837,322 331.19 4.56   1.40%
01/09/19 325.76 330.70 324.46 1,219,477 326.63 2.19   0.68%
01/08/19 324.53 325.90 320.47 1,008,127 324.44 2.04   0.63%
01/07/19 319.28 327.26 317.41 1,305,573 322.40 4.07   1.28%
01/04/19 311.80 323.63 309.90 1,532,500 318.33 11.33   3.69%
01/03/19 306.76 316.69 305.92 2,068,251 307.00 2.31   0.76%
Biogen, Inc. (BIIB) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Biogen, Inc. Stock Analysis

Rating: Buy

Total Grade: B

Analysis Breakdown

BIIB Stock Grade: B
Fundamental Grade: C
Quantitative Grade: B
BIIB Earnings
Earnings Growth: C
Earnings Momentum: F
Earnings Surprises: C
Analyst Earnings Revisions: A
BIIB Financial Information
Sales Growth: C
Operating Margin Growth: C
Cash Flow: C
Return on Equity: A

Biogen, Inc. Stock: Weekly View

This Week: B
Last Week: B
Two Weeks Ago: B
Get Full Report